It is expected that women who experience CIN as an urgent medical condition are more willing to use vaginal probiotics
ID
Bron
Verkorte titel
Aandoening
cervical cancer, HPV clearance
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Willingness to use vaginal probiotics
Acceptance treatment duration vaginal probiotics
Inconvenience of use
Achtergrond van het onderzoek
This survey aims to investigate the experience of women with CIN0/1/2 who use vaginal probiotics in order to increase their HPV clearence. It is relevant to acquire knowledge about the willingness of women with CIN0/1/2 to use probiotics to explore if vaginal probiotics can become part of the standard treatment of cervical dysplasia. As part of the study questionnaires will be distributed among women with HPV positivity and cervical dysplasia (LSIL or HSIL), who have not yet undergone major treatment.
Doel van het onderzoek
It is expected that women who experience CIN as an urgent medical condition are more willing to use vaginal probiotics
Onderzoeksopzet
Primary and secondary outcomes will be collected with a single questionnaire administered 7 days after use of vaginal probiotics
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Women
- with HPV positivity
- who used > 7 days vaginal probiotics
- who can read and write Dutch
- with age 18-65 years old
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
-undergone invasive treatment of the cervix
-HSIL who need invasive treatment
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL9271 |
| Ander register | Raad van Bestuur Diakonessenhuis : 21.011 |